Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Notizia

Notizia

May 28, 2019

Stem cells can regenerate heart

Researchers at the Icahn School of Medicine, U.S.A in their recent study revealed that stem cells extracted from placenta also known as Cdx2 cells might be able to regenerate heart cells after the heart attack. From the beginning, it has been thought that Cdx2 cells could only generate placental cord at early embryonic stages. Additionally, these cells have an extra set of proteins that make them directly travel to the injury site, and regenerate into the specific organ without being attacked by the host immune system. These properties exhibited by the stem cells can help humans immensely.

Novocure receives FDA nods for its Tumor treating field therapy

The U.S. FDA recently gave a green signal to Novocure’s tumour treating electric field system NovoTTF-100L in combination with pemetrexed plus platinum-based chemotherapy for the treatment of unresectable, locally advanced or metastatic, malignant pleural mesothelioma (MPM). MPM is a rare form of cancer that has been strongly linked to asbestos exposure. And this approval will benefit approximately 3,000 people that are diagnosed with MPM in the United States annually.

A study reveals how a common mutation causes Liver cancer

In a recent study, Researchers at Hubrecht Institute and Radboud University in the Netherlands developed a human model using organoids to evaluate the function of specific genes which are commonly mutated in the cancerous liver. Organoids were developed from a healthy human liver and modified using CRISPR/ cas9 gene editing tool solely aimed to study the tumor formation. The study identifies how a gene BAP1 changes the way healthy cells behave accelerating their ability to multiply and metastasise.

Can Gold nanoparticles simplify Gene editing delivery?

Scientists at Fred Hutchinson Cancer Research Center, U.S. found a new delivery truck in the form of gold nanoparticles instead of the earlier used virus that can help couriering gene editing instructions. This is a new approach to simplify gene editing to order to target lethal diseases like HIV and sickle-cell anaemia. The surface of the gold particles allows genes to stick to them easily and stay adhered. This is a step forward to target problems associated with shipping gene editing instructions. This way, gene editing will surely be smoother and simpler.

Downloads

Article in PDF

Recent Articles
  1. US drug approvals plummet in 2016
  2. Notizia
  3. Alnylam’s HELIOS-B Phase III Study of Vutrisiran; Bristol Myers Squibb Secures FDA Nod for ...
  4. Juvenescence raises $46M; Brainsway files for IPO; Life Biosciences raises
  5. Roche’s Gazyva receives FDA Breakthrough designation for Lupus nephritis
pharma-news-for-abbvie-gsk-novartis
Notizia - Recent Pharma, Healthcare and Biotech Happenings

AbbVie Reveals Phase III TEMPO-2 Trial Positive Topline Results; FDA Accepts GSK’s NUCALA Submission in COPD; Novartis Boosts Huntington’s Disease Development Program with PTC518 In-Licensing; Chimerix to File for Accelerated FDA Approval of Dordaviprone for H3 K27M-Mutant Diffuse Glioma; MeiraGTx Receives FDA RMAT Designation for AAV2-hAQP1 in Grade 2/3 Radiation-Induced Xerostomia Treatment

pharma-news-for-applied-therapeutics-alnylam-rigel
Notizia - Recent Pharma, Healthcare and Biotech Happenings

FDA Grants Fast Track for Lin BioScience’s LBS-007; Alnylam’s AMVUTTRA sNDA Under Review; FDA Approves RAPIBLYK for Atrial Fibrillation; Applied Therapeutics Receives CRL for Govorestat in Galactosemia; R289 Gets Fast Track for Lower-Risk MDS.

pharma-news-for-Ractigen-intellia -bridgebio
Notizia - Recent Pharma, Healthcare and Biotech Happenings

FDA Grants Orphan Drug Designation for Ractigen’s RAG-21 in ALS; Intellia’s Nexiguran RMAT for ATTR Amyloidosis; FDA Approves Acoramidis for ATTR-CM; Jazz Wins FDA Approval for Ziihera in HER2-Positive Biliary Cancer; J&J Seeks FDA Approval for Subcutaneous TREMFYA in Colitis

Cell and Gene Therapy
FDA
liver
Novocure
loader